Risk of secondary hematologic malignancies associated with breast cancer chemotherapy and G-CSF support: A nationwide population-based cohort.

International Journal of Cancer. Journal International Du Cancer
Marie Joelle JabagiRosemary Dray-Spira

Abstract

Our study aimed to analyze the risk of hematologic malignancies (HM) associated with the use of G-CSF with chemotherapy for BC. Using the French National Health Data System, we examined the HM risks in patients diagnosed with an incident breast cancer between 2007 and 2015, who received chemotherapy for BC. Main outcomes were acute myeloid leukemia (AML), Myelodysplastic syndrome (MDS), myeloproliferative neoplasms (MPNs), multiple myeloma (MM), Hodgkin lymphoma or non-Hodgkin lymphoma (HL/NHL) and acute lymphoblastic leukemia or lymphocytic lymphoma (ALL/LL). Among a total of 122 373 BC survivors, 38.9% received chemotherapy only and 61.1% received chemotherapy + G-CSF. Overall, 781 cases of hematologic malignancies occurred. We observed a nonsignificant increase in the risk of AML (aHR, 1.3; 95% CI, 1.0-1.7), of MDS (aHR, 1.3; 95% CI, 0.9-1.8) and of ALL/LL (aHR, 2.0; 95% CI, 1.0-4.4) among patients treated by chemotherapy + G-CSF compared to chemotherapy only. In analyses by dose, we observed a slight increase in the risk of AML (1-3 doses: aHR, 1.2; 95% CI, 0.8-1.7/4+ doses: aHR, 1.3; 95% CI, 1.0-1.8) and of MDS (1-3 doses: aHR, 1.1; 95% CI, 0.7-1.7/4+ doses: aHR, 1.4; 95% CI, 1.0-1.9), a significant increase in risk of ALL...Continue Reading

References

Mar 15, 1996·Journal of Neuroscience Research·L MinghettiP Stroobant
Mar 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roy E SmithUNKNOWN National Surgical Adjuvant Breast and Bowel Project Experience
Apr 19, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P L R MitchellM Green
Apr 7, 2004·Journal of Pharmaceutical Sciences·Bing-Bing YangLorin K Roskos
Mar 3, 2005·JAMA : the Journal of the American Medical Association·Hyman B MussUNKNOWN Cancer and Leukemia Group B
Nov 19, 2005·Nature Reviews. Cancer·James M Allan, Lois B Travis
May 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas J SmithAntonio C Wolff
May 12, 2006·The New England Journal of Medicine·Kenneth Kaushansky
Jun 6, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M S AaproUNKNOWN European Organisation for Research and Treatment of Cancer (EORTC) Granulocyte Colony-Stimulating Factor (G-CSF) Guidelines
Jan 20, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Ulrich J M MeyMarcus Gorschlueter
Feb 8, 2007·Journal of the National Cancer Institute·Ivo P Touw, Marijke Bontenbal
Aug 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Debra A PattSharon H Giordano
Jul 24, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G BeadleL Fritschi
Aug 12, 2008·Seminars in Oncology·Lucy A Godley, Richard A Larson
Mar 27, 2009·Breast Cancer Research and Treatment·Mike G MartinMatthew J Walter
Apr 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary H LymanJeffrey Crawford
Aug 25, 2017·Nature Reviews. Cancer·Megan E McNerneyMichelle M Le Beau
Jan 13, 2018·BMJ : British Medical Journal·Jayant S VaidyaJeffrey S Tobias
May 12, 2018·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Glen T SchumockLee C Vermeulen
Jan 19, 2019·JAMA Network Open·Marie Joelle JabagiRosemary Dray-Spira
Jan 23, 2019·JAMA : the Journal of the American Medical Association·Adrienne G Waks, Eric P Winer
Oct 2, 2019·Cancers·Marie Joelle JabagiRosemary Dray-Spira

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.